Recent advances in neuroproteomics

Current Opinion in Molecular Therapeutics

Volumn 9, Issue 3, 2007, Pages 270-281

  Andrade, E C ^a   Krueger, D D ^a   Nairn, A C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

2 DE; Affinity chromatography; Brain; DIGE; Fractionation; Gel electrophoresis; LC MS MS; Organelle; Phosphorylation; Post synaptic density; Proteome

Indexed keywords

ALCOHOL; BETA TUBULIN; BRAIN PROTEIN; CORTICOSTERONE; CYSTEINE; ENOLASE; FLUOXETINE; GLYOXALASE; ILLICIT DRUG; LYSINE; NICOTINE; OPIATE; PARVALBUMIN; PROTEOME; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PSYCHOSTIMULANT AGENT;

AFFINITY CHROMATOGRAPHY; ALCOHOLISM; ANTIBODY AFFINITY; ANXIETY DISORDER; CATION EXCHANGE; DEPRESSION; DRUG DEPENDENCE; FRACTIONATION; GEL ELECTROPHORESIS; HUMAN; IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MENTAL DISEASE; NEUROPROTEOMICS; NONHUMAN; OPIATE ADDICTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEOMICS; REVIEW; REWARD; SCHIZOPHRENIA; TANDEM MASS SPECTROMETRY; TOBACCO DEPENDENCE; TWO DIMENSIONAL ELECTROPHORESIS;

ANIMALS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; NERVOUS SYSTEM DISEASES; PROTEOMICS; TANDEM MASS SPECTROMETRY;

EID: 34250630605     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (103)

1. Lein ES, Hawrylycz MJ, Ao N, Ayres M, Bensinger A, Bernard A, Boe AF, Boguski MS, Brockway KS, Byrnes EJ, Chen L et al: Genome-wide atlas of gene expression in the adult mouse brain. Nature (2007) 445(7124):168-176. •• This paper summarizes the success of the Allen Brain Atlas that has examined the localization by in situ hybridization of more than 22,000 genes in the mouse brain. Notable results obtained are the high percentage of the mouse genome that is expressed in brain, and the fact that many proteins are only found in limited numbers of neuronal subtypes. This research defines the challenge faced by any neuroproteomics study.
2. Williams K, Wu T, Colangelo C, Nairn AC: Recent advances in neuroproteomics and potential application to studies of drug addiction. Neuropharmacology (2004) 47(Suppl 1):148-166.
3. Johnson MD, Yu LR, Conrads TP, Kinoshita Y, Uo T, McBee JK, Veenstra TD, Morrison RS: The proteomics of neurodegeneration. Am J Pharmacogenomics (2005) 5(4):259-270.
4. Butterfield DA, Perluigi M, Sultana R: Oxidative stress in Alzheimer's disease brain: New insights from redox proteomics. Eur J Pharmacol (2006) 545(1):39-50.
5. Tannu NS, Hemby SE: Methods for proteomics in neuroscience. Prog Brain Res (2006) 158:41-82.
6. Lu P, Vogel C, Wang R, Yao X, Marcotte EM: Absolute protein expression profiling estimates the relative contributions of transcriptional and translational regulation. Nat Biotechnol (2007) 25(1):117-124.
7. Olsen JV, Blagoev B, Gnad F, Macek B, Kumar C, Mortensen P, Mann M: Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell (2006) 127(3):635-648.
8. Ong SE, Mann M: Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol (2005) 1(5):252-262.
9. 18O-labeling strategies for quantitative proteomics. Mass Spectrom Rev (2007) 26(1):121-136.
10. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R: Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol (1999) 17(10):994-999.
11. Olsen JV, Nielsen PA, Andersen JR, Mann M, Wisniewski JR: Quantitative proteomic profiling of membrane proteins from the mouse brain cortex, hippocampus, and cerebellum using the HysTag reagent: Mapping of neurotransmitter receptors and ion channels. Brain Res (2007) 1134(1):95-106. • A quantitative proteomics study that compared membrane protein levels in mouse cortex, hippocampus and cerebellum. More than 550 proteins whose expression varied up to 20-fold in different brain regions were identified.
12. Liu T, D'mello V, Deng L, Hu J, Ricardo M, Pan S, Lu X, Wadsworth S, Siekierka J, Birge R, Li H: A multiplexed proteomics approach to differentiate neurite outgrowth patterns. J Neurosci Methods (2006) 158(1):22-29.
13. 2+ ATPase on protein expression in mouse cerebellum.
14. + treatment of synaptosomes.
15. Zieske LR: A perspective on the use of iTRAQ reagent technology for protein complex and profiling studies. J Exp Bot (2006) 57(7):1501-1508.
16. Aggarwal K, Choe LH, Lee KH: Shotgun proteomics using the iTRAQ isobaric tags. Brief Funct Genomic Proteomic (2006) 5(2):112-120.
17. Yu LR, Conrads TP, Uo T, Kinoshita Y, Morrison RS, Lucas DA, Chan KC, Blonder J, Issaq HJ, Veenstra TD: Global analysis of the cortical neuron proteome. Mol Cell Proteomics (2004) 3(9):896-907.
18. Wang H, Qian WJ, Chin MH, Petyuk VA, Barry RC, Liu T, Gritsenko MA, Mottaz HM, Moore RJ, Camp Ii DG, Khan AH et al: Characterization of the mouse brain proteome using global proteomic analysis complemented with cysteinyl-peptide enrichment. J Proteome Res (2006) 5(2):361-369. •• By analyzing samples with and without cysteinyl peptide enrichment, this study used strong cation exchange and MS/MS to identify over 7800 proteins in the mouse brain proteome. This represents the largest global proteomic study of brain tissue to date. All major protein classes were identified in this study, including a large number of membrane proteins (26% of proteins identified).
19. Kislinger T, Cox B, Kannan A, Chung C, Hu P, Ignatchenko A, Scott MS, Gramolini AO, Morris Q, Hallett MT, Rossant J et al: Global survey of organ and organelle protein expression in mouse: Combined proteomic and transcriptomic profiling. Cell (2006) 125(1):173-186.
20. Shin JH, Krapfenbauer K, Lubec G: Large-scale identification of cytosolic mouse brain proteins by chromatographic prefractionation. Electrophoresis (2006) 27(13):2799-2813.
21. Park YM, Kim JY, Kwon KH, Lee SK, Kim YH, Kim SY, Park GW, Lee JH, Lee B, Yoo JS: Profiling human brain proteome by multidimensional separations coupled with MS. Proteomics (2006) 6(18):4978-4986.
22. Nielsen PA, Olsen JV, Podtelejnikov AV, Andersen JR, Mann M, Wisniewski JR: Proteomic mapping of brain plasma membrane proteins. Mol Cell Proteomics (2005) 4(4):402-408.
23. Schindler J, Lewandrowski U, Sickmann A, Friauf E, Nothwang HG: Proteomic analysis of brain plasma membranes isolated by affinity two-phase partitioning. Mol Cell Proteomics (2006) 5(2):390-400.
24. Chen P, Li X, Sun Y, Liu Z, Cao R, He Q, Wang M, Xiong J, Xie J, Wang X, Liang S: Proteomic analysis of rat hippocampal plasma membrane: Characterization of potential neuronal-specific plasma membrane proteins. J Neurochem (2006) 98(4):1126-1140.
25. Vanrobaeys F, Van Coster R, Dhondt G, Devreese B, Van Beeumen J: Profiling of myelin proteins by 2D-gel electrophoresis and multidimensional liquid chromatography coupled to MALDI TOF-TOF mass spectrometry. J Proteome Res (2005) 4(6):2283-2293.
26. Abul-Husn NS, Devi LA: Neuroproteomics of the synapse and drug addiction. J Pharmacol Exp Ther (2006) 318(2):461-468.
27. Witzmann FA, Arnold RJ, Bai F, Hrncirova P, Kimpel MW, Mechref YS, McBride WJ, Novotny MV, Pedrick NM, Ringham HN, Simon JR: A proteomic survey of rat cerebral cortical synaptosomes. Proteomics (2005) 5(8):2177-2201.
28. Schrimpf SP, Meskenaite V, Brunner E, Rutishauser D, Walther P, Eng J, Aebersold R, Sonderegger P: Proteomic analysis of synaptosomes using isotope-coded affinity tags and mass spectrometry. Proteomics (2005) 5(10):2531-2541.
29. Coughenour HD, Spaulding RS, Thompson CM: The synaptic vesicle proteome: A comparative study in membrane protein identification. Proteomics (2004) 4(10):3141-3155.
30. Morciano M, Burre J, Corvey C, Karas M, Zimmermann H, Volknandt W: Immunoisolation of two synaptic vesicle pools from synaptosomes: A proteomics analysis. J Neurochem (2005) 95(6):1732-1745.
31. Jia JY, Lamer S, Schumann M, Schmidt MR, Krause E, Haucke V: Quantitative proteomics analysis of detergent-resistant membranes from chemical synapses: Evidence for cholesterol as spatial organizer of synaptic vesicle cycling. Mol Cell Proteomics (2006) 5(11):2060-2071.
32. Takamori S, Holt M, Stenius K, Lemke EA, Gronborg M, Riedel D, Urlaub H, Schenck S, Brugger B, Ringler P, Muller SA et al: Molecular anatomy of a trafficking organelle. Cell (2006) 127(4):831-846. •• In this comprehensive study, 2-DE with LC-MS/MS was used to identify the components of synaptic vesicles. These included more than 20 SNAREs, and a diverse group of small GTPases. Combining these results with electron micrographs, lipidomics, absolute quantification of proteins, and molecular modeling, allowed for the first molecular rendering of these highly protein-rich organelles.
33. Ritter B, Blondeau F, Denisov AY, Gehring K, McPherson PS: Molecular mechanisms in clathrin-mediated membrane budding revealed through subcellular proteomics. Biochem Soc Trans (2004) 32(5):769-773.
34. Girard M, Allaire PD, McPherson PS, Blondeau F: Non-stoichiometric relationship between clathrin heavy and light chains revealed by quantitative comparative proteomics of clathrin-coated vesicles from brain and liver. Mol Cell Proteomics (2005) 4(8):1145-1154.
35. Tada T, Sheng M: Molecular mechanisms of dendritic spine morphogenesis. Curr Opin Neurobiol (2006) 16(1):95-101.
36. Phillips GR, Florens L, Tanaka H, Khaing ZZ, Fidler L, Yates JR 3rd, Colman DR: Proteomic comparison of two fractions derived from the transsynaptic scaffold. J Neurosci Res (2005) 81(6):762-775.
37. Murata Y, Doi T, Taniguchi H, Fujiyoshi Y: Proteomic analysis revealed a novel synaptic proline-rich membrane protein (PRR7) associated with PSD-95 and NMDA receptor. Biochem Biophys Res Commun (2005) 327(1):183-191.
38. Collins MO, Husi H, Yu L, Brandon JM, Anderson CN, Blackstock WP, Choudhary JS, Grant SG: Molecular characterization and comparison of the components and multiprotein complexes in the postsynaptic proteome. J Neurochem (2006) 97(Suppl 1):16-23. •• This large-scale study examined the PSD proteome by extracting data from previous proteomic studies as well as from 119 primary research papers and their own proteomic analysis of the PSD proteome. In total, 1124 proteins were identified, 466 of which were found in multiple studies and therefore suggested to represent the core PSD (cPSD). This analysis did not include that of Trinidad et al 2006 [39 ••] who identified more than 1200 hundred PSD proteins.
39. Trinidad JC, Specht CG, Thalhammer A, Schoepfer R, Burlingame AL: Comprehensive identification of phosphorylation sites in postsynaptic density preparations. Mol Cell Proteomics (2006) 5(5):914-922. •• Using SCX combined with IMAC, this study identified 723 phosphorylation sites in 1264 PSD proteins. The results obtained indicate that phosphoproteins made up 23% of all proteins found in the PSD under unstimulated conditions.
40. Li KW, Hornshaw MP, van der Schors RC, Watson R, Tate S, Casetta B, Jimenez CR, Gouwenberg Y, Gundelfinger ED, Smalla KH, Smit AB: Proteomics analysis of rat brain postsynaptic density. Implications of the diverse protein functional groups for the integration of synaptic physiology. J Biol Chem (2004) 279(2):987-1002.
41. Yoshimura Y, Yamauchi Y, Shinkawa T, Taoka M, Donai H, Takahashi N, Isobe T, Yamauchi T: Molecular constituents of the postsynaptic density fraction revealed by proteomic analysis using multidimensional liquid chromatography-tandem mass spectrometry. J Neurochem (2004) 88(3):759-768.
42. Peng J, Kim MJ, Cheng D, Duong DM, Gygi SP, Sheng M: Semiquantitative proteomic analysis of rat forebrain postsynaptic density fractions by mass spectrometry. J Biol Chem (2004) 279(20):21003-21011.
43. Cheng D, Hoogenraad CC, Rush J, Ramm E, Schlager MA, Duong DM, Xu P, Wijayawardana SR, Hanfelt J, Nakagawa T, Sheng M, Peng J: Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum. Mol Cell Proteomics (2006) 5(6):1158-1170. • Utilizing ICAT and absolute quantification (AQUA) to determine the absolute amounts of PSD constituents in the rat forebrain and cerebellum, these researchers were able to identify 296 proteins and absolutely quantify 32 proteins known to associate with the PSD.
44. Dosemeci A, Tao-Cheng JH, Vinade L, Jaffe H: Preparation of postsynaptic density fraction from hippocampal slices and proteomic analysis. Biochem Biophys Res Commun (2006) 339(2):687-694.
45. McNair K, Davies CH, Cobb SR: Plasticity-related regulation of the hippocampal proteome. Eur J Neurosci (2006) 23(2):575-580.
46. Li K, Hornshaw MP, van Minnen J, Smalla KH, Gundelfinger ED, Smit AB: Organelle proteomics of rat synaptic proteins: Correlation-profiling by isotope-coded affinity tagging in conjunction with liquid chromatography-tandem mass spectrometry to reveal post-synaptic density specific proteins. J Proteome Res (2005) 4(3):725-733. • This quantitative proteomics study used ICAT to measure protein enrichment in the PSD fraction relative to a less pure membrane fraction. Greater than 50% of proteins identified (69 of 129) were not enriched in the PSD fraction, especially mitochondrial proteins, while a subset of proteins were highly enriched which likely represent core PSD proteins. Immunoelectron microscopy was used to validate the proteomics results.
47. Azarkan M, Huet J, Baeyens-Volant D, Looze Y, Vandenbussche G: Affinity chromatography: A useful tool in proteomics studies. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 849(1-2):81-90.
48. Collins MO, Yu L, Coba MP, Husi H, Campuzano I, Blackstock WP, Choudhary JS, Grant SG: Proteomic analysis of in vivo phosphorylated synaptic proteins. J Biol Chem (2005) 280(7):5972-5982. •• Enrichment of phosphoproteins and/or phosphopeptides using IMAC allowed the identification of 650 phosphorylation events in rat synaptosomes, which corresponded to 331 sites contained in 79 proteins.
49. 2+-calmodulin affinity chromatography and tandem mass spectrometry. J Proteome Res (2006) 5(3):669-687.
50. Vosseller K, Trinidad JC, Chalkley RJ, Specht CG, Thalhammer A, Lynn AJ, Snedecor JO, Guan S, Medzihradszky KF, Maltby DA, Schoepfer R, Burlingame AL: O-linked N-acetylglucosamine proteomics of postsynaptic density preparations using lectin weak affinity chromatography and mass spectrometry. Mol Cell Proteomics (2006) 5(5):923-934.
51. Ballif BA, Cao Z, Schwartz D, Carraway KL 3rd, Gygi SP: Identification of 14-3-3ε substrates from embryonic murine brain. J Proteome Res (2006) 5(9):2372-2379.
52. Olsen O, Moore KA, Fukata M, Kazuta T, Trinidad JC, Kauer FW, Streuli M, Misawa H, Burlingame AL, Nicoll RA, Bredt DS: Neurotransmitter release regulated by a MALS-liprin-α presynaptic complex. J Cell Biol (2005) 170(7):1127-1134.
53. Wang QJ, Ding Y, Kohtz DS, Mizushima N, Cristea IM, Rout MP, Chait BT, Zhong Y, Heintz N, Yue Z: Induction of autophagy in axonal dystrophy and degeneration. J Neurosci (2006) 26(31):8057-8068.
54. Cristea IM, Williams R, Chait BT, Rout MP: Fluorescent proteins as proteomic probes. Mol Cell Proteomics (2005) 4(12):1933-1941.
55. Sutton MA, Schuman EM: Dendritic protein synthesis, synaptic plasticity, and memory. Cell (2006) 127(1):49-58.
56. Dieterich DC, Link AJ, Graumann J, Tirrell DA, Schuman EM: Selective identification of newly synthesized proteins in mammalian cells using bioorthogonal noncanonical amino acid tagging (BONCAT). Proc Natl Acad Sci USA (2006) 103(25):9482-9487. • To detect newly synthesized proteins, this study utilized the incorporation of modified amino acids, in a method termed bioorthogonal noncanonical amino acid tagging (BONCAT). Tagged proteins were then purified by affinity chromatography and identified by tandem MS methods. This approach allowed for spatial and temporal characterization of protein synthesis.
57. Angenstein F, Evans AM, Ling SC, Settlage RE, Ficarro S, Carrero-Martinez FA, Shabanowitz J, Hunt DF, Greenough WT: Proteomic characterization of messenger ribonucleoprotein complexes bound to nontranslated or translated poly(A) mRNAs in the rat cerebral cortex. J Biol Chem (2005) 280(8):6496-6503.
58. Gafken PR, Lampe PD: Methodologies for characterizing phosphoproteins by mass spectrometry. Cell Commun Adhes (2006) 13(5-6):249- 262.
59. Ballif BA, Villen J, Beausoleil SA, Schwartz D, Gygi SP: Phosphoproteomic analysis of the developing mouse brain. Mol Cell Proteomics (2004) 3(11):1093-1101.
60. DeGiorgis JA, Jaffe H, Moreira JE, Carlotti CG Jr, Leite JP, Pant HC, Dosemeci A: Phosphoproteomic analysis of synaptosomes from human cerebral cortex. J Proteome Res (2005) 4(2):306-315.
61. Raggiaschi R, Lorenzetto C, Diodato E, Caricasole A, Gotta S, Terstappen GC: Detection of phosphorylation patterns in rat cortical neurons by combining phosphatase treatment and DIGE technology. Proteomics (2006) 6(3):748-756.
62. Semenov A, Goldsteins G, Castren E: Phosphoproteomic analysis of neurotrophin receptor TrkB signaling pathways in mouse brain. Cell Mol Neurobiol (2006) 26(2):163-175.
63. Trinidad JC, Thalhammer A, Specht CG, Schoepfer R, Burlingame AL: Phosphorylation state of postsynaptic density proteins. J Neurochem (2005) 92(6):1306-1316.
64. Field D, Sansone SA: A special issue on data standards. OMICS (2006) 10(2):84-93.
65. Hamacher M, Meyer HE: HUPO Brain Proteome Project: Aims and needs in proteomics. Expert Rev Proteomics (2005) 2(1):1-3.
66. Taylor CF: Minimum reporting requirements for proteomics: A MIAPE primer. Proteomics (2006) 6(Suppl 2):39-44.
67. Hamacher M, Apweiler R, Arnold G, Becker A, Bluggel M, Carrette O, Colvis C, Dunn MJ, Frohlich T, Fountoulakis M, van HA et al: HUPO Brain Proteome Project: Summary of the pilot phase and introduction of a comprehensive data reprocessing strategy. Proteomics (2006) 6(20):5674 (Erratum). •• This and the other articles in the September 2006 issue of Proteomics summarize recent research of the Brian Proteome Project (HUPO BPP). The various articles address advances and pitfalls in sample preparation, proteomic methodology, data set sharing, and data analysis.
68. Hamacher M, Marcus K, van Hall A, Meyer HE, Stephan C: The HUPO Brain Proteome Project - no need to hurry? J Neural Transm (2006) 113(8):963-971.
69. Beasley CL, Pennington K, Behan A, Wait R, Dunn MJ, Cotter D: Proteomic analysis of the anterior cingulate cortex in the major psychiatric disorders: Evidence for disease-associated changes. Proteomics (2006) 6(11):3414-3425.
70. Clark D, Dedova I, Cordwell S, Matsumoto I: A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia. Mol Psychiatry (2006) 11(5):459-470.
71. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA et al: Mitochondrial dysfunction in schizophrenia: Evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry (2004) 9(7):684-697, 643.
72. La YJ, Wan CL, Zhu H, Yang Y, Chen Y, Pan Y, Ji B, Feng G, He L: Hippocampus protein profiling reveals aberration of malate dehydrogenase in chlorpromazine/clozapine treated rats. Neurosci Lett (2006) 408(1):29-34.
73. La YJ, Wan CL, Zhu H, Yang YF, Chen YS, Pan YX, Feng GY, He L: Decreased levels of apolipoprotein A-I in plasma of schizophrenic patients. J Neural Transm (2007) 114(5):657-663.
74. Schlicht K, Buttner A, Siedler F, Scheffer B, Zill P, Eisenmenger W, Ackenheil M, Bondy B: Comparative proteomic analysis with postmortem prefrontal cortex tissues of suicide victims versus controls. J Psychiatr Res (2007) 41(6):493-501.
75. Skynner HA, Amos DP, Murray F, Salim K, Knowles MR, Munoz-Sanjuan I, Camargo LM, Bonnert TP, Guest PC: Proteomic analysis identifies alterations in cellular morphology and cell death pathways in mouse brain after chronic corticosterone treatment. Brain Res (2006) 1102(1):12-26. • Using DIGE, 30, 54 and 33 proteins were identified that were altered by corticosterone treatment in the hypothalamus, hippocampus and cortex, respectively. Of these, nine were found to change in all three regions. Immunoblotting confirmed the changes in expression levels of glutathione S-transferase Mu1, Hsp90α, neurofilament medium chain, and ezrin P81 in all three brain regions.
76. Carboni L, Piubelli C, Pozzato C, Astner H, Arban R, Righetti PG, Hamdan M, Domenici E: Proteomic analysis of rat hippocampus after repeated psychosocial stress. Neuroscience (2006) 137(4):1237-1246.
77. Carboni L, Vighini M, Piubelli C, Castelletti L, Milli A, Domenici E: Proteomic analysis of rat hippocampus and frontal cortex after chronic treatment with fluoxetine or putative novel antidepressants: CRF1 and NK1 receptor antagonists. Eur Neuropsychopharmacol (2006) 16(7):521-537.
78. Khawaja X, Xu J, Liang JJ, Barrett JE: Proteomic analysis of protein changes developing in rat hippocampus after chronic antidepressant treatment: Implications for depressive disorders and future therapies. J Neurosci Res (2004) 75(4):451-460.
79. Kromer SA, Kessler MS, Milfay D, Birg IN, Bunck M, Czibere L, Panhuysen M, Putz B, Deussing JM, Holsboer F, Landgraf R, Turck CW: Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety. J Neurosci (2005) 25(17):4375-4384. • This study utilized 2-DE to detect differences in the amygdala of animals outbred to have high or low anxiety-related behavior. Using multiple validation techniques, animals with low anxiety-related behavior showed increased levels of glyoxalase-1.
80. Ding Q, Vaynman S, Souda P, Whitelegge JP, Gomez-Pinilla F: Exercise affects energy metabolism and neural plasticity-related proteins in the hippocampus as revealed by proteomic analysis. Eur J Neurosci (2006) 24(5):1265-1276.
81. Hemby SE: Assessment of genome and proteome profiles in cocaine abuse. Prog Brain Res (2006) 158:173-195.
82. Tannu N, Mash DC, Hemby SE: Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol Psychiatry (2007) 12(1):55-73.
83. Alexander-Kaufman K, James G, Sheedy D, Harper C, Matsumoto I: Differential protein expression in the prefrontal white matter of human alcoholics: A proteomics study. Mol Psychiatry (2006) 11(1):56-65.
84. Lewohl JM, Van Dyk DD, Craft GE, Innes DJ, Mayfield RD, Cobon G, Harris RA, Dodd PR: The application of proteomics to the human alcoholic brain. Ann NY Acad Sci (2004) 1025:14-26.
85. Neuhold LA, Guo QM, Alper J, Velazquez JM: High-throughput proteomics for alcohol research. Alcohol Clin Exp Res (2004) 28(2):203-210.
86. Yeom M, Shim I, Lee HJ, Hahm DH: Proteomic analysis of nicotine-associated protein expression in the striatum of repeated nicotine-treated rats. Biochem Biophys Res Commun (2005) 326(2):321-328.
87. Hwang YY, Li MD: Proteins differentially expressed in response to nicotine in five rat brain regions: Identification using a 2-DE/MS-based proteomics approach. Proteomics (2006) 6(10):3138-3153.
88. Robinson TE, Kolb B: Structural plasticity associated with exposure to drugs of abuse. Neuropharmacology (2004) 47(Suppl 1):33-46.
89. Prokai L, Zharikova AD, Stevens SM Jr: Effect of chronic morphine exposure on the synaptic plasma-membrane subproteome of rats: A quantitative protein profiling study based on isotope-coded affinity tags and liquid chromatography/mass spectrometry. J Mass Spectrom (2005) 40(2):169-175.
90. Moron JA, Abul-Husn NS, Rozenfeld R, Dolios G, Wang R, Devi LA: Morphine administration alters the profile of hippocampal postsynaptic density-associated proteins: A proteomics study focusing on endocytic proteins. Mol Cell Proteomics (2007) 6(1):29-42. • Protein expression in the postsynaptic density from hippocampus was examined using ICAT following morphine exposure in mouse. Immunoblotting and immuno-electron microscopy was used to confirm the altered expression of three of the proteins (clathrin, Na/K ATPase and 14-3-3). Follow-up studies also showed that morphine appeared to alter the phosphorylation of dynamin, and to increase the association of clathrin with the GluR1 glutamate receptor.
91. Papassotiropoulos A, Fountoulakis M, Dunckley T, Stephan DA, Reiman EM: Genetics, transcriptomics, and proteomics of Alzheimer's disease. J Clin Psychiatry (2006) 67(4):652-670.
92. Bierczynska-Krzysik A, Pradeep John JP, Silberring J, Kotlinska J, Dylag T, Cabatic M, Lubec G: Proteomic analysis of rat cerebral cortex, hippocampus and striatum after exposure to morphine. Int J Mol Med (2006) 18(4):775-784.
93. Li KW, Jimenez CR, van der Schors RC, Hornshaw MP, Schoffelmeer AN, Smit AB: Intermittent administration of morphine alters protein expression in rat nucleus accumbens. Proteomics (2006) 6(6):2003-2008.
94. Kim SY, Chudapongse N, Lee SM, Levin MC, Oh JT, Park HJ, Ho IK: Proteomic analysis of phosphotyrosyl proteins in the rat brain: Effect of butorphanol dependence. J Neurosci Res (2004) 77(6):867-877.
95. Kim SY, Chudapongse N, Lee SM, Levin MC, Oh JT, Park HJ, Ho IK: Proteomic analysis of phosphotyrosyl proteins in morphine-dependent rat brains. Brain Res Mol Brain Res (2005) 133(1):58-70.
96. Freeman WM, Brebner K, Amara SG, Reed MS, Pohl J, Phillips AG: Distinct proteomic profiles of amphetamine self-administration transitional states. Pharmacogenomics J (2005) 5(3):203-214.
97. Iwazaki T, McGregor IS, Matsumoto I: Protein expression profile in the striatum of acute methamphetamine-treated rats. Brain Res (2006) 1097(1):19-25.
98. Liao PC, Kuo YM, Hsu HC, Cherng CG, Yu L: Local proteins associated with methamphetamine-induced nigrostriatal dopaminergic neurotoxicity. J Neurochem (2005) 95(1):160-168.
99. Bell RL, Kimpel MW, Rodd ZA, Strother WN, Bai F, Peper CL, Mayfield RD, Lumeng L, Crabb DW, McBride WJ, Witzmann FA: Protein expression changes in the nucleus accumbens and amygdala of inbred alcohol-preferring rats given either continuous or scheduled access to ethanol. Alcohol (2006) 40(1):3-17.
100. Damodaran S, Dlugos CA, Wood TD, Rabin RA: Effects of chronic ethanol administration on brain protein levels: a proteomic investigation using 2-D DIGE system. Eur J Pharmacol (2006) 547(1-3):75-82.
101. Van den Oever MC, Spijker S, Li KW, Jimenez CR, Koya E, van der Schors RC, Gouwenberg Y, Binnekade R, De Vries TJ, Schoffelmeer AN, Smit AB: A proteomics approach to identify long-term molecular changes in rat medial prefrontal cortex resulting from sucrose self-administration. J Proteome Res (2006) 5(1):147-154.
102. Anderson CN, Grant SG: High throughput protein expression screening in the nervous system - needs and limitations. J Physiol (2006) 575(2):367-372.
103. Becker M, Schindler J, Nothwang HG: Neuroproteomics - the tasks lying ahead. Electrophoresis (2006) 27(13):2819-2829.